Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cidara Therapeutics (CDTX) Total Debt: 2017-2021

Historic Total Debt for Cidara Therapeutics (CDTX) over the last 5 years, with Dec 2021 value amounting to $2.6 million.

  • Cidara Therapeutics' Total Debt fell 92.30% to $370,000 in Q2 2022 from the same period last year, while for Jun 2022 it was $370,000, marking a year-over-year decrease of 92.30%. This contributed to the annual value of $2.6 million for FY2021, which is 63.11% down from last year.
  • Latest data reveals that Cidara Therapeutics reported Total Debt of $2.6 million as of FY2021, which was down 63.11% from $7.0 million recorded in FY2020.
  • In the past 5 years, Cidara Therapeutics' Total Debt ranged from a high of $10.0 million in FY2019 and a low of $2.6 million during FY2021.
  • In the last 3 years, Cidara Therapeutics' Total Debt had a median value of $7.0 million in 2020 and averaged $6.5 million.
  • In the last 5 years, Cidara Therapeutics' Total Debt climbed by 0.56% in 2018 and then plummeted by 63.11% in 2021.
  • Over the past 5 years, Cidara Therapeutics' Total Debt (Yearly) stood at $9.9 million in 2017, then rose by 0.56% to $9.9 million in 2018, then grew by 0.37% to $10.0 million in 2019, then fell by 29.52% to $7.0 million in 2020, then crashed by 63.11% to $2.6 million in 2021.